annual accounts payable:
$43.60M+$15.56M(+55.48%)Summary
- As of today (June 2, 2025), MDGL annual accounts payable is $43.60 million, with the most recent change of +$15.56 million (+55.48%) on December 31, 2024.
- During the last 3 years, MDGL annual accounts payable has risen by +$22.22 million (+103.92%).
- MDGL annual accounts payable is now at all-time high.
Performance
MDGL Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$42.06M-$1.54M(-3.54%)Summary
- As of today (June 2, 2025), MDGL quarterly accounts payable is $42.06 million, with the most recent change of -$1.54 million (-3.54%) on March 31, 2025.
- Over the past year, MDGL quarterly accounts payable has increased by +$20.53 million (+95.35%).
- MDGL quarterly accounts payable is now -8.51% below its all-time high of $45.97 million, reached on September 30, 2024.
Performance
MDGL quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MDGL Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +55.5% | +95.3% |
3 y3 years | +103.9% | +84.6% |
5 y5 years | +3601.1% | +3671.8% |
MDGL Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +103.9% | -8.5% | +367.6% |
5 y | 5-year | at high | +4187.0% | -8.5% | +4035.3% |
alltime | all time | at high | >+9999.0% | -8.5% | >+9999.0% |
MDGL Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $42.06M(-3.5%) |
Dec 2024 | $43.60M(+55.5%) | $43.60M(-5.1%) |
Sep 2024 | - | $45.97M(+411.1%) |
Jun 2024 | - | $8.99M(-58.2%) |
Mar 2024 | - | $21.53M(-23.2%) |
Dec 2023 | $28.04M(+17.7%) | $28.04M(+69.5%) |
Sep 2023 | - | $16.54M(-5.7%) |
Jun 2023 | - | $17.53M(+44.6%) |
Mar 2023 | - | $12.13M(-49.1%) |
Dec 2022 | $23.83M(+11.5%) | $23.83M(+28.4%) |
Sep 2022 | - | $18.56M(+64.4%) |
Jun 2022 | - | $11.29M(-50.4%) |
Mar 2022 | - | $22.78M(+6.5%) |
Dec 2021 | $21.38M(+2002.3%) | $21.38M(+105.2%) |
Sep 2021 | - | $10.42M(+876.4%) |
Jun 2021 | - | $1.07M(-75.7%) |
Mar 2021 | - | $4.40M(+332.3%) |
Dec 2020 | $1.02M(-13.7%) | $1.02M(-83.8%) |
Sep 2020 | - | $6.28M(+25.4%) |
Jun 2020 | - | $5.00M(+348.8%) |
Mar 2020 | - | $1.11M(-5.3%) |
Dec 2019 | $1.18M(-52.6%) | $1.18M(+52.4%) |
Sep 2019 | - | $773.00K(+73.3%) |
Jun 2019 | - | $446.00K(-89.8%) |
Mar 2019 | - | $4.38M(+76.0%) |
Dec 2018 | $2.49M(+28.9%) | $2.49M(+141.2%) |
Sep 2018 | - | $1.03M(+75.3%) |
Jun 2018 | - | $588.00K(-58.6%) |
Mar 2018 | - | $1.42M(-26.4%) |
Dec 2017 | $1.93M(+153.1%) | $1.93M(+37.8%) |
Sep 2017 | - | $1.40M(+8.9%) |
Jun 2017 | - | $1.28M(-53.8%) |
Mar 2017 | - | $2.78M(+264.8%) |
Dec 2016 | $762.00K(+644.9%) | $762.00K(-34.3%) |
Sep 2016 | - | $1.16M(+70.6%) |
Jun 2016 | - | $680.00K(-8.6%) |
Mar 2016 | - | $744.00K(+627.3%) |
Dec 2015 | $102.30K | $102.30K(-92.8%) |
Sep 2015 | - | $1.42M(-52.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $3.02M(-19.3%) |
Mar 2015 | - | $3.74M(+19.1%) |
Dec 2014 | $3.14M(-52.4%) | $3.14M(-29.3%) |
Sep 2014 | - | $4.44M(-15.0%) |
Jun 2014 | - | $5.23M(-10.1%) |
Mar 2014 | - | $5.81M(-11.8%) |
Dec 2013 | $6.59M(+16.4%) | $6.59M(+15.7%) |
Sep 2013 | - | $5.69M(+9.0%) |
Jun 2013 | - | $5.22M(-8.7%) |
Mar 2013 | - | $5.72M(+1.0%) |
Dec 2012 | $5.66M(+63.3%) | $5.66M(+53.4%) |
Sep 2012 | - | $3.69M(+6.4%) |
Jun 2012 | - | $3.47M(+14.1%) |
Mar 2012 | - | $3.04M(-12.3%) |
Dec 2011 | $3.47M(+80.1%) | $3.47M(+18.7%) |
Sep 2011 | - | $2.92M(+46.1%) |
Jun 2011 | - | $2.00M(+18.2%) |
Mar 2011 | - | $1.69M(-12.2%) |
Dec 2010 | $1.93M(-51.4%) | $1.93M(-19.6%) |
Sep 2010 | - | $2.39M(+87.0%) |
Jun 2010 | - | $1.28M(-12.4%) |
Mar 2010 | - | $1.46M(-63.1%) |
Dec 2009 | $3.96M(+18.8%) | $3.96M(-12.8%) |
Sep 2009 | - | $4.54M(-24.3%) |
Jun 2009 | - | $6.00M(-43.5%) |
Mar 2009 | - | $10.62M(+218.7%) |
Dec 2008 | $3.33M(+33.9%) | $3.33M(+66.6%) |
Sep 2008 | - | $2.00M(+35.9%) |
Jun 2008 | - | $1.47M(-67.5%) |
Mar 2008 | - | $4.53M(+82.1%) |
Dec 2007 | $2.49M(-5.5%) | $2.49M(+26.3%) |
Sep 2007 | - | $1.97M(-0.6%) |
Jun 2007 | - | $1.98M(+8.7%) |
Mar 2007 | - | $1.82M(-30.8%) |
Dec 2006 | $2.63M(-21.7%) | $2.63M(+48.1%) |
Sep 2006 | - | $1.78M(-47.1%) |
Dec 2005 | $3.36M(+16.5%) | $3.36M(-17.2%) |
Mar 2005 | - | $4.06M |
Dec 2004 | $2.88M(+1280.4%) | - |
Dec 2003 | $209.00K | - |
FAQ
- What is Madrigal Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual accounts payable year-on-year change?
- What is Madrigal Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly accounts payable year-on-year change?
What is Madrigal Pharmaceuticals annual accounts payable?
The current annual accounts payable of MDGL is $43.60M
What is the all time high annual accounts payable for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual accounts payable is $43.60M
What is Madrigal Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, MDGL annual accounts payable has changed by +$15.56M (+55.48%)
What is Madrigal Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of MDGL is $42.06M
What is the all time high quarterly accounts payable for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly accounts payable is $45.97M
What is Madrigal Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, MDGL quarterly accounts payable has changed by +$20.53M (+95.35%)